Posterior segment manifestations of Takayasu arteritis: A narrative review.

Pukhraj Rishi, Ekta Rishi, Unnati Sharma, Rajiv Raman, Vishali Gupta

Journal: Indian journal of ophthalmology 2024;72(5):637-647

PMID: 38648432

Abstract

Ocular symptoms can be the presenting manifestation of Takayasu arteritis (TA) or could be indicative of disease reactivation. A review of published literature related to posterior segment manifestations of TA by using the keywords "Takayasu arteritis," "ophthalmic manifestations," "retina," "retinopathy," "ocular," "optic nerve," and "optic neuropathy" was performed. In total, 62 case reports and 12 case series were included. The majority of the articles were from Asia (n = 47, 64%). Females outnumbered males in the ratio of 7:1. The mean age of patients was 33 years (range: 8-78 years, SD: 13.5 years). In 58% (n = 41 out of 71) cases, ocular symptoms were the presenting manifestation of the underlying disease. Hypotensive retinopathy was found in 70% of eyes, and hypertensive retinopathy was found in 27%. The mean presenting visual acuity (VA) was +1.03 logMAR (range: -0.12 to 3, SD: 1.07), and at the final follow-up was +1.02 logMAR (range: -0.12 to 3, SD 1.17). VA improved in 34% (n = 29/86), remained stable in 45% (39/86), and worsened in 21% (18/86). The mean follow-up was 9 months (range: 0.5-204, SD: 16 months).

Copyright © 2024 Copyright: © 2024 Indian Journal of Ophthalmology.

Address: Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India.; Truhlsen Eye Institute, University of Nebraska Medical Centre, Omaha, NE, USA.; Advanced Eye Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India.; Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.